lanthanum has been researched along with Phosphorus Metabolism Disorders in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ritz, E | 1 |
| D'Haese, PC; De Broe, ME | 1 |
| Hutchison, AJ | 1 |
| Behets, GJ; D'Haese, PC; De Broe, ME; Verberckmoes, SC | 1 |
| Querfeld, U | 1 |
| Al-Baaj, F; Hutchison, AJ; Speake, M | 1 |
| Albaaj, F; Hutchison, AJ | 2 |
| Finn, WF; Joy, MS | 1 |
| Aime, S; Canavese, C; Mereu, C; Nordio, M; Sabbioni, E | 1 |
| Bellasi, A; Block, GA; Kooienga, L | 1 |
| Cerny, S; Kunzendorf, U | 1 |
| Altmann, P; Barnett, ME; Finn, WF | 1 |
| Brancaccio, D; Cozzolino, M | 4 |
| Freemont, AJ | 1 |
| Bellinghieri, G; Santoro, D; Savica, V | 1 |
| Chen, JY; Chiou, SY; Chuang, CL; Jian, DY; Li, SY | 1 |
11 review(s) available for lanthanum and Phosphorus Metabolism Disorders
| Article | Year |
|---|---|
Improving outcomes in hyperphosphataemia.
Topics: Clinical Trials, Phase II as Topic; Humans; Lanthanum; Phosphates; Phosphorus Metabolism Disorders | 2004 |
Improving phosphate-binder therapy as a way forward.
Topics: Clinical Trials as Topic; Epoxy Compounds; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Polyethylenes; Sevelamer | 2004 |
Lanthanum carbonate: a new phosphate binder.
Topics: Bone and Bones; Buffers; Clinical Trials as Topic; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus; Phosphorus Metabolism Disorders | 2004 |
The therapeutic potential of novel phosphate binders.
Topics: Child; Epoxy Compounds; Humans; Kidney Failure, Chronic; Lanthanum; Phosphorus Metabolism Disorders; Polyamines; Polyethylenes; Sevelamer | 2005 |
Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients.
Topics: Clinical Trials as Topic; Humans; Lanthanum; Phosphates; Phosphorus Metabolism Disorders; Renal Dialysis; Renal Insufficiency | 2005 |
Blast from the past: the aluminum's ghost on the lanthanum salts.
Topics: Area Under Curve; Chelating Agents; Humans; Kidney Failure, Chronic; Lanthanum; Phosphorus Metabolism Disorders; Renal Dialysis | 2005 |
Lanthanum carbonate (Fosrenol): a novel agent for the treatment of hyperphosphataemia in renal failure and dialysis patients.
Topics: Bone and Bones; Calcium; Humans; Kidney Failure, Chronic; Lanthanum; Parathyroid Hormone; Phosphorus Metabolism Disorders; Randomized Controlled Trials as Topic; Renal Dialysis; Safety | 2005 |
Phosphate binders: new products and challenges.
Topics: Aluminum; Bile Acids and Salts; Calcium; Humans; Lanthanum; Niacinamide; Phosphates; Phosphorus Metabolism Disorders; Polymers; Renal Dialysis | 2006 |
Lanthanum carbonate.
Topics: Animals; Bone and Bones; Clinical Trials as Topic; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus Metabolism Disorders; Trace Elements | 2006 |
Hyperphosphatemia in dialysis patients: the therapeutic role of lanthanum carbonate.
Topics: Chelating Agents; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2007 |
Emerging drugs for hyperphosphatemia.
Topics: Animals; Atherosclerosis; Calcinosis; Calcium Phosphates; Chelating Agents; Drugs, Investigational; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Saliva; Sevelamer; Uremia | 2007 |
3 trial(s) available for lanthanum and Phosphorus Metabolism Disorders
| Article | Year |
|---|---|
Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-term, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Double-Blind Method; Female; Humans; Lanthanum; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Phosphorus Metabolism Disorders; Renal Dialysis; Time Factors | 2005 |
A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis.
Topics: Adolescent; Adult; Aged; Calcium; Dose-Response Relationship, Drug; Female; Humans; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Phosphorus Metabolism Disorders; Renal Dialysis; Time Factors; Treatment Outcome | 2005 |
Cognitive function in Stage 5 chronic kidney disease patients on hemodialysis: no adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy.
Topics: Adult; Aged; Cognition; Female; Humans; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Renal Dialysis | 2007 |
7 other study(ies) available for lanthanum and Phosphorus Metabolism Disorders
| Article | Year |
|---|---|
Managing mineral balance in end-stage renal disease.
Topics: Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus Metabolism Disorders | 2004 |
Images in clinical medicine. Radiographic appearance of lanthanum.
Topics: Aged, 80 and over; Colon; Humans; Kidney Failure, Chronic; Lanthanum; Male; Phosphates; Phosphorus Metabolism Disorders; Radiography | 2006 |
Lanthanum carbonate--new data on parathyroid hormone control without liver damage.
Topics: Humans; Kidney Failure, Chronic; Lanthanum; Nephrectomy; Parathyroid Hormone; Phosphorus Metabolism Disorders; Treatment Outcome | 2007 |
Lanthanum carbonate: time to abandon prejudices?
Topics: Aluminum; Animals; Bone and Bones; Brain; Humans; Lanthanum; Liver; Phosphates; Phosphorus Metabolism Disorders; Rats | 2007 |
Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.
Topics: Calcium Carbonate; Chelating Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Europe; Humans; Kidney Failure, Chronic; Lanthanum; Phosphorus Metabolism Disorders; Randomized Controlled Trials as Topic; Renal Dialysis; United States | 2007 |
Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease.
Topics: Atherosclerosis; Calcinosis; Calcium Phosphates; Chelating Agents; Drugs, Investigational; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer; Uremia | 2007 |
The case: a peritoneal dialysis patient with an unusual abdominal film. Treatment with lanthanum carbonate.
Topics: Adult; Edema; Female; Humans; Lanthanum; Leg; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus Metabolism Disorders; Radiography, Abdominal; Time Factors | 2007 |